scholarly article | Q13442814 |
P819 | ADS bibcode | 2010PLoSO...511284L |
P356 | DOI | 10.1371/JOURNAL.PONE.0011284 |
P932 | PMC publication ID | 2890406 |
P698 | PubMed publication ID | 20585642 |
P5875 | ResearchGate publication ID | 44807336 |
P50 | author | Kenneth J Smith | Q43175898 |
Richard Zimmerman | Q42658961 | ||
Ann E Wiringa | Q56774930 | ||
Rachel B. Slayton | Q56774942 | ||
Bruce Y. Lee | Q65555428 | ||
Sarah M McGlone | Q106457677 | ||
Shanta M Zimmer | Q114338917 | ||
P2860 | cites work | Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease | Q44084354 |
Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States | Q44276981 | ||
Performance characteristics of clinical diagnosis, a clinical decision rule, and a rapid influenza test in the detection of influenza infection in a community sample of adults | Q44841385 | ||
Diagnosing influenza--clinical assessment and/or rapid antigen testing? | Q45052229 | ||
Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) Virus - United States, 2009. | Q45382219 | ||
Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans | Q45383194 | ||
Treat or test first? Decision analysis of empirical antiviral treatment of influenza virus infection versus treatment based on rapid test results. | Q45731703 | ||
Cost-effectiveness of treating influenzalike illness with oseltamivir in the United States | Q45810645 | ||
Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America | Q48585293 | ||
Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. | Q48719424 | ||
Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis. | Q50754705 | ||
Evaluation of four real-time PCR assays for detection of influenza A(H1N1)v viruses. | Q54479219 | ||
Does This Patient Have Influenza? | Q22252995 | ||
Neuraminidase inhibitors for preventing and treating influenza in healthy adults | Q24244898 | ||
Vaccines for preventing influenza in the elderly | Q24245325 | ||
Vaccines for preventing influenza in healthy adults | Q24246585 | ||
Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis | Q24644585 | ||
Antivirals for influenza in healthy adults: systematic review. | Q30352729 | ||
Post-exposure influenza prophylaxis with oseltamivir: cost effectiveness and cost utility in families in the UK. | Q30353815 | ||
Antivirals and influenza: frequency of resistance. | Q30372305 | ||
Rapid antigen tests for diagnosis of pandemic (Swine) influenza A/H1N1. | Q30380340 | ||
Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial | Q31931976 | ||
Influenza outbreak during Sydney World Youth Day 2008: the utility of laboratory testing and case definitions on mass gathering outbreak containment | Q33499697 | ||
Influenza virus resistance to antiviral agents: a plea for rational use. | Q33701528 | ||
One thousand health-related quality-of-life estimates | Q33937445 | ||
Cost-effectiveness of newer treatment strategies for influenza | Q33961752 | ||
Prevention and treatment of influenza | Q34103251 | ||
Influenza. Cost of illness and considerations in the economic evaluation of new and emerging therapies | Q34219687 | ||
Neuraminidase inhibitors for influenza | Q34455162 | ||
Management of influenza symptoms in healthy adults | Q34742405 | ||
Prevalence and seasonality of influenza-like illness in children, Nicaragua, 2005-2007 | Q37189492 | ||
The impact of influenza on working days lost: a review of the literature | Q37292575 | ||
Cost effectiveness of oseltamivir treatment of influenza: a critique of published methods and outcomes | Q37486665 | ||
Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza | Q40596066 | ||
Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group | Q40625504 | ||
Low sensitivity of rapid diagnostic test for influenza. | Q54489183 | ||
Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak | Q57099517 | ||
The utility of different health states as perceived by the general public | Q67429353 | ||
Cost effectiveness of zanamivir for the treatment of influenza in a high risk population in Australia | Q74287490 | ||
Toward consistency in cost-utility analyses: using national measures to create condition-specific values | Q74660492 | ||
How sensitive are cost-effectiveness analyses to choice of parametric distributions? | Q80977056 | ||
Cost-effectiveness of universal influenza vaccination in a pregnant population | Q83886549 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e11284 | |
P577 | publication date | 2010-06-23 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | To test or to treat? An analysis of influenza testing and antiviral treatment strategies using economic computer modeling | |
P478 | volume | 5 |
Q30235281 | A Narrative Review of Influenza: A Seasonal and Pandemic Disease |
Q36215695 | An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine. |
Q50069031 | Automated influenza case detection for public health surveillance and clinical diagnosis using dynamic influenza prevalence method. |
Q92381089 | Cost-Effective Respiratory Virus Testing |
Q36559794 | Cost-effectiveness analysis of antiviral treatment in the management of seasonal influenza A: point-of-care rapid test versus clinical judgment. |
Q40713908 | Cost-effectiveness of an influenza vaccination program offering intramuscular and intradermal vaccines versus intramuscular vaccine alone for elderly |
Q40105670 | Cost-effectiveness of molecular point-of-care testing for influenza viruses in elderly patients at ambulatory care setting |
Q49989122 | Cost-utility analysis of antiviral use under pandemic influenza using a novel approach - linking pharmacology, epidemiology and heath economics. |
Q34171619 | Cost-utility of rapid polymerase chain reaction-based influenza testing for high-risk emergency department patients. |
Q93537719 | Current Best Practices for Respiratory Virus Testing |
Q30353587 | Influenza testing, diagnosis, and treatment in the emergency department in 2009-2010 and 2010-2011 |
Q30398368 | Interdisciplinary pharmacometrics linking oseltamivir pharmacology, influenza epidemiology and health economics to inform antiviral use in pandemics. |
Q36434424 | Performance of a Novel Point-of-Care Molecular Assay for Detection of Influenza A and B Viruses and Respiratory Syncytial Virus (Enigma MiniLab) in Children with Acute Respiratory Infection. |
Q36231674 | Potential Cost-Effectiveness of an Influenza Vaccination Program Offering Microneedle Patch for Vaccine Delivery in Children. |
Q37147720 | Prevention of influenza in healthy children |
Q30410029 | Rethinking approaches to improve the utilization of nucleic acid amplification tests for detection and characterization of influenza A in diagnostic and reference laboratories |
Q34111130 | Socioeconomic impact of seasonal (epidemic) influenza and the role of over-the-counter medicines |
Q28481328 | Systematic review of economic evaluations of preparedness strategies and interventions against influenza pandemics |
Q30398941 | The 2009 H1N1 influenza pandemic: a case study of how modeling can assist all stages of vaccine decision-making |
Q35652153 | The cost of an Ebola case |
Q29587258 | The potential economic burden of Zika in the continental United States |
Q90177670 | Utility of Rapid Influenza Molecular Testing in an Outpatient Hemodialysis Unit: A Prospective Cohort Study |
Search more.